FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Chlorothiazide (Diuril) Oral Suspension
Status: Currently in Shortage
»Date first posted: 08/12/2020
»Therapeutic Categories: Cardiovascular; Pediatric

Bausch Health (New 08/12/2020)

Company Contact Information:

Presentation Availability and Estimated Shortage Duration Related Information Shortage Reason (per FDASIA)
250 mg/5 mL (50 mg/mL) 237 mL (NDC 65649-311-12) Product availability is planned for 18-Sep-2020. Distributor-Salix Pharmaceuticals, Inc.: 1-800-321-4576 Shortage of an inactive ingredient

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English